A novel cancer vaccine composed of human-recombinant epidermal growth factor linked to a carrier protein: Report of a pilot clinical trial

Annals of Oncology

Volumn 9, Issue 4, 1998, Pages 431-435

  Gonzalez G ^a   Crombet, T ^a   Catala M ^b   Mirabal, V ^b   Hernandez J C ^b   Gonzalez Y ^a   Marinello, P ^a   Guillen G ^c   Lage, A ^a  

^a CENTER OF MOLECULAR IMMUNOLOGY   (Cuba)

^b Medical Surgical Research Center   (Cuba)

^c CENTER FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Cuba)

Author keywords

Cancer vaccine; Epidermal growth factor

Indexed keywords

CANCER VACCINE; CARRIER PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR; RECOMBINANT EPIDERMAL GROWTH FACTOR; TETANUS TOXOID;

ACTIVE IMMUNIZATION; ADULT; AGED; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; DRUG SAFETY; DRUG TOLERABILITY; ERYTHEMA; FEMALE; GENE OVEREXPRESSION; HUMAN; IMMUNOGENICITY; MALE; PRIORITY JOURNAL; PRURITUS; VACCINATION;

EID: 0031775979     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008261031034     Document Type: Article

References (24)

1. Carpenter G, Cohen S. EGF receptors interaction and the stimulation of cell growth. In Lefkowitz RJ (ed): Receptor Regulation (Series B), Vol. 13. London/New York: Chapman and Hall 1981; 41.
2. Ulrich A, Schlessinger J. Signal transduction by receptors with tyrosine kinase activity. Cell 1990; 61: 203-12.
3. Cohen S. Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the new born animal. J Biol Chem 1962; 237: 1555-62.
4. Përez R, Pascual MR, Macias A et al. Epidermal growth factor receptors in human breast cancer. Breast Cancer Res Treat 1984; 4: 189-93.
5. Klijn JG, Look MP, Portengen H et al. The prognostic value of epidermal growth factor receptor (EGF-R) in primary breast cancer. Results of a 10-year follow-up study. Breast Cancer Res Treat 1994; 4: 189-93.
6. Rios MA, Macías A, Pérez R et al. Receptors for epidermal growth factor and estrogen as predictors of relapse in patients with mammary carcinoma. Anticancer Res 1988; 8: 173-6.
7. Macias A, Azavedo E, Perez R et al. Receptors for epidermal growth factor in human carcinomas and their metastases. Anticancer Res 1986; 6: 849-52.
8. Macías A, Perez R, Hagerstrom T et al. Transforming Growth Factor Alpha in Human mammary carcinomas and their metastases. Anticanccr Res 1989; 177-80.
9. Rush V, Baselga J, Cordon-Cardo C et al. Differential expression of the epidermal growth factor receptor and its ligands in primary non-small cell lung cancers and adjacent benign lung. Cancer Res 1993; 53: 2379-85.
10. Ware JL. Growth factors and their receptors as determinants in the proliferation and metastasis of human prostate cancer. Cancer Metastasis Rev 1993; 12: 287-301.
11. Dassonoville O, Formento JL, Francoual M et al. Expression of epidermal growth factor receptor and survival in upper aerodigestive tract cancer. J Clin Oncol 1993; 11: 1873-8.
12. Jaminis J, Nakopoulou G et al. Immunohistochemical expression of EGF-R in malignant surface epithelial ovarian neoplasms (SEON). Eur J Gynaecol Oncol 1994; 15: 19-23.
13. Iida A, Hirose K, Arai M et al. Relationships among the expression of epidermal growth factor receptor, proliferation cell nuclear antigen labeling index, and lymph node metastasis in gastric cancer. Oncology 1995; 52: 189-95.
14. Ichiyochi Y, Tateishi M, Toda T et al. Epidermal growth factor in gastric carcinoma as a risk of postoperative recurrence. Int Surg 1993; 78: 196-9.
15. Diuigi CR, Well S, Kris M et al. Phase I and imagin trial of indium 111 labeled anti-epidermal growth factor receptor monoclonal antibody 225 in patients with squamous cell lung carcinoma. J Natl Cancer Inst 1991; 83: 97-104.
16. Brady IW, Markal AM, Woo DV et al. Iodine 125-labeled anti-epidermal growth factor receptor 425 in the treatment of Glioblastoma Multiforme Front. Radiat Ther Oncol 1990; 24: 151-60.
17. Baselga J, Mendelson J. The epidermal growth factor receptor as target for therapy in breast carcinoma. Breast Cancer Res Treat 1994; 127-38.
18. González G, Sánchez B, Suárez E et al. Induction of immune recognition of self epidermal growth factor (EGF): Effect on EGF biodistribution and tumor growth. Vaccine Res 1996; 5: 233-44.
19. Guillén G, Silva R, Alvarez A et al. Cloning and expression of a high molecular weigh protein (PM-6) from the Neisseria meningitidis strain B: 4P1.15. Evaluation of the immunogenicity and bacterial activity of antibodies raised against the recombinant protein. Pathology and immunobiology of Neisseriaceae. In Conde CJ et al. (eds): INSP Méxinci 1994; 834-40.
20. Silva R, Selman M, Guillén G et al. Nucleotide sequence coding for an outer membrane protein from Neisseria meningitidis and use of said sequence in vaccine preparations. USA Patent 1994; 5: 286-484.
21. Raaberg L, Nexo E, Poulsen SS et al. An immunologic approach to induction of epidermal growth factor deficiency. Induction and characterization of autoantibodies to epidermal growth factor in rats. Pediatr Res 1995; 37: 169-74.
22. Raaberg L, Nexo E, Jorgensen PE et al. Fetal effects of epidermal growth factor deficiency induced in rats by autoantibodies against epidermal growth factor. Pediatr Res 1995; 175-81.
23. Cohen I. The cognitive principle challenges clonal selection. Immunol Today 1992; 13: 441-4.
24. Cohen I. The cognitive paradigm and the immunological homunculus. Immunol Today 1992; 13: 490-4.